Supernus Pharmaceuticals, Inc. (SUPN): Depreciation & Amortization
$91.56M
Year ended 2025-12-31
$101.70M
Trailing 12 months to 2026-06-30
+2.3%
3-year compound annual growth
+38.2%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $91.56M | +13.9% | 2026-03-02, From 2025-01-01 |
| 2024-12-31 | $80.41M | -5.2% | 2026-03-02, From 2024-01-01 |
| 2023-12-31 | $84.86M | -0.8% | 2026-03-02, From 2023-01-01 |
| 2022-12-31 | $85.54M | +162.4% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | $32.59M | +79.7% | 2023-03-09, From 2021-01-01 |
| 2020-12-31 | $18.14M | +172.4% | 2023-03-09, From 2020-01-01 |
| 2019-12-31 | $6.66M | -5.7% | 2022-04-13, From 2019-01-01 |
| 2018-12-31 | $7.06M | -13.1% | 2021-03-08, From 2018-01-01 |
| 2017-12-31 | $8.13M | +239.0% | 2020-02-28, From 2017-01-01 |
| 2016-12-31 | $2.40M | +160.5% | 2019-03-01, From 2016-01-01 |
| 2015-12-31 | $921.0K | -0.8% | 2018-03-01, From 2015-01-01 |
| 2014-12-31 | $928.0K | +25.1% | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | $742.0K | -14.8% | 2017-01-20, From 2013-01-01 |
| 2012-12-31 | $871.0K | -0.9% | 2015-03-12, From 2012-01-01 |
| 2011-12-31 | $879.0K | -26.0% | 2014-03-21, From 2011-01-01 |
| 2010-12-31 | $1.19M | n/a | 2013-03-15, From 2010-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. (SUPN) | 2025-12-31 | $91.56M | +13.9% |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $91.02M | +15.5% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $95.80M | -11.9% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $1.15M | +44.5% |
| Kiniksa Pharmaceuticals International, plc (KNSA) | 2025-12-31 | $1.55M | -8.3% |
| Ultragenyx Pharmaceutical Inc. (RARE) | 2025-12-31 | $35.00M | -2.8% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $22.20M | +31.4% |
| TG Therapeutics, Inc. (TGTX) | 2025-12-31 | $59.0K | -13.2% |
| Opko Health, Inc. (OPK) | 2025-12-31 | $91.63M | -6.7% |
Compare SUPN, PCRX, EBS, CORT side by side · Screen every company in Pharmaceutical Preparations ↗